Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 2003, p. 1717-1719, Vol. 41, No. 4
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.4.1717-1719.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
St. John Hospital & Medical Center, Detroit, Michigan
Received 23 July 2002/ Returned for modification 27 September 2002/ Accepted 16 January 2003
|
|
|---|
|
|
|---|
(A preliminary report of this work has been presented previously [R. Khatib, M. Sharma, S. A. H. Naqvi, K. Riederer, M. O. Almoujahed, and M. G. Fakih, Abstr. 41st Intersci. Conf. Antimicrob. Agents Chemother., abstr. K-1430, 2001.])
The study was conducted at a single 607-bed teaching hospital. BC and intravascular catheter (IVC) tip cultures were prospectively monitored (1 January 2000 to 1 May 2001). All patients with one or more positive BC during the first 2 months and all patients with >15 CFU of S. aureus in IVC tip cultures and positive BC during all 5 months of the study were screened for inclusion. The medical records of selected patients were reviewed. All patients with bacteremia (determined by clinical signs of infection and a positive culture obtained from a peripheral blood draw) were included in the study. Patients with contaminated BC (determined by a single positive BC without a clear source of bacteremia, which was judged by the attending physician to be from a contaminant, and where there was no utilization of antibiotics with antistaphylococcal activity) and polymicrobial bacteremia were excluded. Determination of the source of the bacteremia was based on clinical signs of infection and supported by isolation of S. aureus with an antibiotic susceptibility pattern identical to that of the implicated source.
The first blood isolate and the IVC tip isolate were chosen for analysis. Positive BC were plated on a Trypticase soy agar plate (TSA) with 5% sheep blood and incubated for 24 h at 35°C. IVC tips were cultured by a semiquantitative method (3). They were not sonicated. S. aureus identification was based on catalase production and Staphaureux latex agglutination (Murex Biotech Ltd., Dartford, England). Susceptibility tests were performed with Vitek gram-positive susceptibility cards (bioMérieux, Hazelwood, Mo.).
The primary blood agar plate of BC and IVC tip cultures was used to minimize in vitro variation in colony populations due to differential growth characteristics. Eight colonies were randomly selected from each BC and IVC isolate and saved individually at -80°C until tested.
Genomic DNA was extracted and subjected to endonuclease digestion and pulsed-field gel electrophoresis (PFGE) as previously described (9). Restriction patterns were compared visually by three independent observers. The isolates were considered indistinguishable if all DNA bands matched, related if there were differences in one to three bands, and distinct if there were differences in more than three bands (11, 12).
Twenty-nine patients with positive BC were encountered; eight patients with bacteremia were excludedthree because of contaminated BC, three because of mixed infections, and two because the BC were not saved. Thirty-three patients had S. aureus in an IVC tip culture; 13 of these patients were excludedsix with cultures with <15 CFU and seven without bacteremia. Thus, we studied 21 patients with bacteremia from a variety of sources and 20 patients with IVC-associated bacteremia by using available blood and IVC isolates. The IVC tip and BC isolates from all patients had identical susceptibility patterns.
The mean age (± standard deviation) of the study group was 63.1 ± 19.2 years (range, 5 months to 88 years), and 23 of the patients were males (56.1%). Bacteremia was device associated in 33 patients (74.2%) (IVC, 27 patients; osteomyelitis with hardware, 4 patients; pacemaker, 1 patient; atrial-venous graft, 1 patient) and non-device associated in 8 patients (skin and soft tissue infections, 7 patients; infective endocarditis, 1 patient). The infections were nosocomial in 21 patients (51.2%). The isolates were oxacillin resistant in 61% of the patients.
The typing of eight colonies or isolates was completed for 39 blood and 18 IVC isolates. Of the remainder, only seven colonies were typed in two blood isolates and one IVC isolate and six colonies were typed in one IVC isolate. The remaining colonies proved to be Staphylococcus epidermidis in three instances and a Micrococcus species in one instance; these colonies were considered contaminants.
Analysis of the entire group (41 patients) revealed 22 PFGE types. Thirteen types were detected among 25 methicillin-resistant S. aureus (MRSA) isolates (nine types of each were unique to one patient, two types of each were noted in three patients, and two more types of each were encountered among five patients), and nine types were detected among 16 methicillin-susceptible (MSSA) S. aureus isolates (five types of each were unique to a single patient, three types of each were detected in two patients, and one type was detected in five patients).
Individual case analysis of blood isolates revealed indistinguishable banding patterns in all of the colonies (100% monoclonal population; 95% confidence interval, 63.1 to 100%) from 39 patients (95.1%) and in 7 of 8 colonies (87.5% monoclonal population; 95% confidence interval, 47.4 to 99.7%) from 2 patients (4.9%) with IVC-associated bacteremia. Colony morphologies were identical in all patients.
Analysis of the IVC isolates revealed variation in colony morphology and/or hemolytic characteristics in four patientstwo patients with MRSA infections and two patients with MSSA infections. All morphological variants had identical banding patterns. All patients with diversified IVC populations had monoclonal blood isolates (Table 1).
|
View this table: [in a new window] |
TABLE 1. Molecular analysis of S. aureus isolates from IVCs and BC from individual patients with IVC-associated bacteremia
|
Our findings demonstrate that all of the S. aureus blood isolates were monoclonal, with occasional minor clone variation. The monoclonal nature of the isolates was also demonstrable in patients whose IVC isolates showed genotypic diversity. Thus, the current practice of selecting 3 to 5 representative colonies of S. aureus from BC for antimicrobial susceptibility testing remains reliable.
The detection of related variants in a small number of IVC and blood isolates was an interesting finding. Whether this finding reflects minor genotypic changes at the implicated site, in the bloodstream, or in vitro during culture is uncertain.
There are a few limitations to our study. We attempted to minimize in vitro variation in colony populations due to differential growth characteristics by selecting colonies from the primary blood agar plate of the BC and catheter tip cultures. However, blood was first cultured in a broth medium. Therefore, we cannot be certain that selection did not occur. Additionally, the number of patients with polyclonal source isolates was small. Examining additional patients and including isolates from other sources might have disclosed more frequent polyclonal bacteremia. Finally, utilizing additional typing methods might have provided better discrimination, but performing extra analysis of 488 colonies would be prohibitive.
We thank Amir Khosrovaneh for his assistance in analyzing the PFGE results.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»